Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01359046 · ClinicalTrials.gov registry record · NA
Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
NCT01359046: Completed NA study, sponsored by Mayo Clinic.
NCT01359046 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01359046, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
Study Summary
The purpose of this study is to compare urinary tract infection rates among women undergoing urogynecological procedures with a silver-alloy suprapubic catheter compared to the standard suprapubic catheter.
Interventions
- DEVICE silver SPC
- DEVICE standard SPC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2011-07 |
| Est. Completion | 2018-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01359046
The ClinicalTrials.gov registry entry for NCT01359046 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which silver SPC is the first listed.
NCT01359046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01359046 about?
NCT01359046 is a clinical study titled "Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology". The purpose of this study is to compare urinary tract infection rates among women undergoing urogynecological procedures with a silver-alloy suprapubic catheter compared to the standard suprapubic catheter.
What is the current status of trial NCT01359046?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2011-07. Estimated completion is 2018-03-09.
What interventions are being tested in trial NCT01359046?
The interventions under investigation include: silver SPC (DEVICE), standard SPC (DEVICE).
Who is sponsoring clinical trial NCT01359046?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.